LAB.001 SPRL
The score of LAB.001 shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Total assets +90 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LAB.001's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 25 Sep 2024
- Year ended 31 Dec 2022filed on 11 Jul 2024
- Year ended 31 Dec 2021filed on 22 Jul 2022
- Year ended 31 Dec 2020filed on 16 Jul 2021
LAB.001's financial analysis
- Solvency8.6%sector median: 45.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LAB.001
LAB.001's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0863.946.534
- VAT number
- BE0863946534
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 10 Mar 2004
- Registered office
- 1000 Brussels
- Latest accounts
- 2024 · filed on 30 Aug 2025
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
LAB.001 (SPRL) has been based in Brussels since 2004, active in: research and experimental development on other natural sciences and engineering. For 2024, it reports a net loss of 9,468 € and equity of 455 €; its revenue is not published. Its solvency stands at 8.6%, below the median of its sector (45.7%).
Companies similar to LAB.001
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- RK21 Research and experimental development on natural sciences and engineering Hamois · balance sheet 3,336 €
- Phagomed Research and experimental development on natural sciences and engineering Izegem · balance sheet 8,901 €
- Indagen Research and experimental development on natural sciences and engineering Antwerp · balance sheet 10,059 €
- NASK Research and experimental development on natural sciences and engineering Dilbeek · balance sheet 2,027 €
- Euraxi Research and experimental development on natural sciences and engineering Liège · balance sheet 15,180 €
Frequently asked questions about LAB.001
What is the revenue of LAB.001?
LAB.001 files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of LAB.001?
In Belgium, the VAT number is the company number prefixed with BE: BE0863946534 for LAB.001, if the company is VAT-registered. Its company number (CBE) is 0863.946.534.
Where is the registered office of LAB.001?
According to the CBE register, the registered office of LAB.001 is in 1000 Brussels.
What is the equity of LAB.001?
At the close of the 2024 financial year, the equity of LAB.001 amounts to 455 €, a solvency of 8.6% of total assets.
Who manages LAB.001?
The register lists 1 active mandates at LAB.001. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LAB.001
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →